AVENOSO, DANIELE
 Distribuzione geografica
Continente #
EU - Europa 1.468
AS - Asia 20
SA - Sud America 7
NA - Nord America 1
Totale 1.496
Nazione #
IT - Italia 1.468
CN - Cina 11
BR - Brasile 5
SG - Singapore 4
VN - Vietnam 4
AR - Argentina 2
IQ - Iraq 1
US - Stati Uniti d'America 1
Totale 1.496
Città #
Genoa 747
Genova 386
Vado Ligure 230
Rapallo 99
Bordighera 6
Beijing 3
Ashburn 1
Hanoi 1
Ho Chi Minh City 1
Hurlingham 1
Hải Dương 1
Passo Fundo 1
Peruíbe 1
Porto Real 1
Posadas 1
Santa Maria de Itabira 1
Singapore 1
São Paulo 1
Totale 1.483
Nome #
Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide 191
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question". 151
Hepatosplenic T-cell lymphoma with aberrant expression of serum β-HCG: A case report 126
Haploientical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography 117
Epigenetic Regulation in Myelodysplastic Syndrome as A Consequence of A MicroRNA Dysregulation 104
VALUTAZIONE D’ESPRESSIONE DI MICRO-RNA IN PAZIENTI AFFETTI DA MIELODISPLASIA. UN POSSIBILE STRUMENTO UTILE PER LA COMPRESIONE DELLA PATOGENESI E DEI MECCANISMI DI PROGRESSIONE DI MALATTIA 103
Next Generation Sequencing and Microrna Assay in a Cohort of Patients Affected By Myelodysplastic Syndromes. an Analysis of Clinical and Genotypic Features 62
Case report – Prolonged SARS-CoV-2 positive PCR after resolution of symptoms 59
Systematic screening and focused evaluation for venous occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatment 36
Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT 34
Lymphoid blast crisis after prolonged treatment‐free remission in chronic myeloid leukaemia after tyrosine kinase inhibitor de‐escalation during the COVID‐19 pandemic 33
SARS-CoV-2 infection in aplastic anemia 33
Modern views of nutritional support in patients undergoing allogeneic stem cell transplantation 32
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy 30
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation 29
Early and late-onset veno-occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation - a real-world UK experience 27
ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party 27
Thymoma and pure red cell aplasia with hypoplasia of megakaryocytopoiesis: A rare and life-treating condition 27
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party 27
Human parainfluenza virus type 3 infections in a haemato-oncology unit: social distancing measures needed in outpatient clinics 26
CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy 25
Microbial Contamination of Haematopoietic Stem Cell Products: A Single Centre Experience 25
Myeloablative dose of busulfan and fludarabine combined with in vivo T-cell depletion is a safe and effective conditioning for acute myeloid leukaemia and myelodysplastic syndrome patients 23
A Cellular Therapy with Haploidentical Peripheral Hematopoietic Stem Cell Transplantation MAY be a Therapeutic Option in Patients with Relapsed Lymphoma with Chemorefractory Disease 23
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study 22
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure Lymphoma 21
Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia‐related changes with megakaryoblastic differentiation 21
Systematic screening and focused evaluation for veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatment 20
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease 20
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT 17
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience 16
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients 14
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT 11
Thymoma and pure red cell aplasia with hypoplasia of megakaryocytopoiesis: A rare and life-treating condition 9
Second allogeneic haematopoietic stem cell transplant conditioned with treosulfan and fludarabine is associated with encouraging overall survival and transplant related mortality in late relapse of myeloid malignancies 9
Totale 1.550
Categoria #
all - tutte 7.111
article - articoli 6.358
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 428
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 10 3 6 5 8 5 5 6
2021/2022111 5 7 4 8 3 14 6 22 12 9 2 19
2022/2023127 10 9 4 8 15 14 3 5 27 1 29 2
2023/2024180 3 7 3 28 14 22 5 45 12 18 4 19
2024/2025552 16 48 14 30 81 58 41 75 17 17 47 108
2025/2026285 120 43 66 44 12 0 0 0 0 0 0 0
Totale 1.550